ALVR
Price
$9.63
Change
-$0.20 (-2.03%)
Updated
Feb 21 closing price
Capitalization
48.55M
67 days until earnings call
MRVI
Price
$4.11
Change
+$0.16 (+4.05%)
Updated
Feb 21 closing price
Capitalization
582.98M
2 days until earnings call
Ad is loading...

ALVR vs MRVI

Header iconALVR vs MRVI Comparison
Open Charts ALVR vs MRVIBanner chart's image
AlloVir
Price$9.63
Change-$0.20 (-2.03%)
Volume$5.1K
Capitalization48.55M
Maravai LifeSciences Holdings
Price$4.11
Change+$0.16 (+4.05%)
Volume$5.47M
Capitalization582.98M
ALVR vs MRVI Comparison Chart
Loading...
ALVR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALVR vs. MRVI commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALVR is a Hold and MRVI is a Hold.

Ad is loading...
COMPARISON
Comparison
Feb 23, 2025
Stock price -- (ALVR: $9.63 vs. MRVI: $4.11)
Brand notoriety: ALVR and MRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALVR: 19% vs. MRVI: 261%
Market capitalization -- ALVR: $48.55M vs. MRVI: $582.98M
ALVR [@Biotechnology] is valued at $48.55M. MRVI’s [@Biotechnology] market capitalization is $582.98M. The market cap for tickers in the [@Biotechnology] industry ranges from $393.7B to $0. The average market capitalization across the [@Biotechnology] industry is $2.45B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALVR’s FA Score shows that 1 FA rating(s) are green whileMRVI’s FA Score has 1 green FA rating(s).

  • ALVR’s FA Score: 1 green, 4 red.
  • MRVI’s FA Score: 1 green, 4 red.
According to our system of comparison, both ALVR and MRVI are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALVR’s TA Score shows that 3 TA indicator(s) are bullish while MRVI’s TA Score has 4 bullish TA indicator(s).

  • ALVR’s TA Score: 3 bullish, 5 bearish.
  • MRVI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, MRVI is a better buy in the short-term than ALVR.

Price Growth

ALVR (@Biotechnology) experienced а -2.73% price change this week, while MRVI (@Biotechnology) price change was -2.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.71%. For the same industry, the average monthly price growth was -2.01%, and the average quarterly price growth was +0.86%.

Reported Earning Dates

ALVR is expected to report earnings on May 01, 2025.

MRVI is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Biotechnology (-1.71% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRVI($583M) has a higher market cap than ALVR($48.6M). ALVR YTD gains are higher at: -0.311 vs. MRVI (-24.587). MRVI has higher annual earnings (EBITDA): 548M vs. ALVR (-79.43M). ALVR has less debt than MRVI: ALVR (0) vs MRVI (561M). MRVI has higher revenues than ALVR: MRVI (277M) vs ALVR (0).
ALVRMRVIALVR / MRVI
Capitalization48.6M583M8%
EBITDA-79.43M548M-14%
Gain YTD-0.311-24.5871%
P/E RatioN/AN/A-
Revenue0277M-
Total CashN/A578M-
Total Debt0561M-
TECHNICAL ANALYSIS
Technical Analysis
ALVRMRVI
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 3 days ago
80%
Bearish Trend 2 days ago
87%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
84%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 9 days ago
79%
Bullish Trend 17 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 2 days ago
81%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bearish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
ALVR
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MACHX20.96-0.21
-0.99%
MoA Balanced Fund
MRLVX28.41-0.40
-1.39%
BlackRock Advantage Large Cap Val R
WFICX14.25-0.27
-1.86%
North Star Small Cap Value Institutional
MCFOX5.58-0.14
-2.45%
BlackRock Large Cap Focus Growth Inv C
OTIIX56.44-1.46
-2.52%
T. Rowe Price Small-Cap Stock I

ALVR and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALVR has been loosely correlated with MDGL. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if ALVR jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALVR
1D Price
Change %
ALVR100%
-2.03%
MDGL - ALVR
46%
Loosely correlated
-4.22%
XNCR - ALVR
38%
Loosely correlated
-0.32%
ATAI - ALVR
37%
Loosely correlated
-2.45%
SGMO - ALVR
37%
Loosely correlated
-4.46%
ERAS - ALVR
37%
Loosely correlated
-3.42%
More

MRVI and

Correlation & Price change

A.I.dvisor indicates that over the last year, MRVI has been loosely correlated with ALVR. These tickers have moved in lockstep 35% of the time. This A.I.-generated data suggests there is some statistical probability that if MRVI jumps, then ALVR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MRVI
1D Price
Change %
MRVI100%
+4.05%
ALVR - MRVI
35%
Loosely correlated
-2.03%
AXON - MRVI
34%
Loosely correlated
-5.28%
VCYT - MRVI
33%
Loosely correlated
-4.56%
OCEA - MRVI
32%
Poorly correlated
-9.12%
ERAS - MRVI
31%
Poorly correlated
-3.42%
More